Assessment of T cell function with a skin allograft assay

Transplantation
A E Chang, P H Sugarbaker

Abstract

The adoptive transfer of cytotoxic effector cells to induce accelerated skin allograft rejection in the normal murine host was used as an assay of lymphocyte function in vivo. Splenocytes sensitized in vivo caused specific accelerated skin allograft rejection when administered i.v. at a dose of 5 X 10(7) cells 1 day after grafting. Graft rejection was specific for the immunizing alloantigen and could not be transferred with freeze-thawed or irradiated cytotoxic cells. In this assay the i.v. and local routes of administering cytotoxic cells were effective whereas the i.p. and s.c. routes were not. T cells were necessary in that pretreatment of the cells with anti-Thy-1.2 plus rabbit complement abrogated this phenomenon. Immune cells from spleens of mice sensitized but no longer actively cytotoxic did not demonstrate in vivo activity. If hyperimmunized mice were challenged by i/p. allogeneic tumor, their spleen cells were highly cytotoxic by in vitro assay but acted as suppressor cells in vivo by prolonging skin graft survival. Adoptively transferred in vivo sensitized cells subsequently expanded in number by T cell growth factor did not demonstrate in vivo activity. This skin allograft assay may be used to demonstrate T cell act...Continue Reading

Citations

May 1, 1989·Research in Immunology·M W KieranA Israel
Aug 15, 2002·Transplantation Proceedings·W WaegellS Banerjee
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·D De RuysscherE van der Schueren
Feb 1, 1982·Cellular Immunology·M M Kemeny, P H Sugarbaker
Jun 1, 1982·The Journal of Surgical Research·M M Kemeny, P H Sugarbaker
Oct 15, 1983·International Journal of Cancer. Journal International Du Cancer·H BinzH Wigzell
Jan 1, 1984·Immunological Reviews·N L TilneyT B Strom
Jan 1, 1984·Immunological Reviews·N L AscherR L Simmons

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.